homeostasis/metabolism
immune system
• diffuse lymphocyte bundles
|
• inflammation
|
• diffuse lymphocyte bundles
|
• B cells express high levels of the early activation marker CD69
|
• T cells express high levels of the early activation marker CD69
|
• CD138+ plasma-cell hyperplasia is observed in the spleen and lymph nodes
|
• in spleen of 13 to 26 month old mice
|
• development of secondary lymphoid follicles and CD138+plasma-cell hyperplasia is
observed in the spleen and lymph nodes
|
• diffuse lymphocyte bundles
|
• mesangio-proliferative glomerulonephritis in 21 of 26 mice that first manifests at the age of 3 months and progresses with age
|
neoplasm
• microvessel density is significantly reduced in B16 melanoma derived tumors
|
• characterized by a wide focus of ischemic-coagulative necrosis 17 days after B16 injection
• tumor cells have a significantly lower proliferation index and higher number of apoptotic cells 17 days after B16 injection than wild-type mice
|
• decreased B16 melonama derived tumor size 17 days after subcutaneous injection
|
• epithelial lung tumors such as bronchoalveolar carcinoma of the lung in older mice
|
• 4 of 13 mice older than 12 months show mature plasmacytoma histologic features
|
cardiovascular system
• microvessel density is significantly reduced in B16 melanoma derived tumors
|
renal/urinary system
• mesangio-proliferative glomerulonephritis in 21 of 26 mice that first manifests at the age of 3 months and progresses with age
|
hematopoietic system
• B cells express high levels of the early activation marker CD69
|
• T cells express high levels of the early activation marker CD69
|
liver/biliary system
• diffuse lymphocyte bundles
|
digestive/alimentary system
• diffuse lymphocyte bundles
|
• inflammation
|
• diffuse lymphocyte bundles
|
endocrine/exocrine glands
• diffuse lymphocyte bundles
|
• inflammation
|
• diffuse lymphocyte bundles
|
respiratory system
• epithelial lung tumors such as bronchoalveolar carcinoma of the lung in older mice
|